
TC BioPharm Delists American Depositary Shares

I'm PortAI, I can summarize articles.
TC BioPharm (Holdings) plc has filed to deregister and delist its American Depositary Shares (ADS), each representing 4,000 Ordinary shares. The decision impacts these ADS securities, with 18 holders of record. The filing was signed by CFO Martin Thorp. This information was published via the U.S. SEC's EDGAR system on December 3, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

